Related Experiment Video
Updated: Sep 13, 2025

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Small vessels, big problem: a dive into the pulmonary microcirculation in pulmonary hypertension and methods for
Misha Dagan1, Shane Nanayakkara2, William Chan3
1Department of Cardiology, Alfred Hospital, Melbourne, Australia; Monash University, Faculty of Medicine, Nursing and Health Sciences, Clayton, Melbourne, Australia.
None:
Pulmonary microvascular dysfunction is central to the pathophysiology of pulmonary hypertension (PH), yet remains challenging to evaluate in clinical practice. This review outlines current and emerging methodologies for assessing the pulmonary microcirculation, including advanced imaging, computational modelling, and invasive haemodynamic techniques. Exercise right heart catheterisation, waveform analysis, and vasoreactivity testing provide indirect insights into microvascular health, while novel invasive approaches, such as pulmonary flow reserve and pulmonary microvascular resistance indices, offer the potential for more precise functional characterisation. Computational models incorporating CT-derived anatomical data and patient-specific haemodynamics may enhance early detection and phenotyping of PH. Although many of these tools remain in the research domain, their refinement and integration into clinical workflows could enable earlier diagnosis, personalised risk stratification, and monitoring of therapeutic response. Ultimately, translating these innovations into practice may allow for targeted interventions that address microvascular dysfunction at an earlier stage of disease progression.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Embolism I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

